絞り込み

16645

広告

ALW peptide ameliorates lupus nephritis in MRL/lpr mice.

著者 Wang H , Lu M , Zhai S , Wu K , Peng L , Yang J , Xia Y
Arthritis Res Ther.2019 Dec 02 ; 21(1):261.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

Miscellaneous

Lupus nephritis (LN) is a common and serious complication of systemic lupus erythematosus. Anti-double-stranded (ds) DNA immunoglobulin G (IgG) plays a pivotal role in the pathogenesis of LN. Currently, there are various therapies for patients with LN; however, most of them are associated with considerable side effects. We confirmed previously that ALW (ALWPPNLHAWVP), a 12-amino acid peptide, inhibited the binding of polyclonal anti-dsDNA antibodies to mesangial cells and isolated glomeruli in vitro. In this study, we further investigate whether the administration of ALW peptide decreases renal IgG deposition and relevant damage in MRL/lpr lupus-prone mice.
PMID: 31791413 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード